Effect of using fidaxomicin on recurrent Clostridium difficile infection
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference15 articles.
1. Clostridium difficile infection: epidemiology, diagnosis and understanding transmission;Martin;Nat Rev Gastroenterol Hepatol,2016
2. Contribution to Clostridium difficile transmission of symptomatic patients with toxigenic strains who are fecal toxin negative;Mawer;Clin Infect Dis,2017
3. Toxin immunoassays and Clostridium difficile infection – reply;Polage;JAMA Intern Med,2016
4. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C. difficile infection;Planche;Lancet Infect Dis,2013
5. Real world use in a large UK tertiary hospital: how effective is it for treating recurrent disease?;Enoch;J Hosp Infect,2018
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Oral fidaxomicin versus vancomycin for the treatment of Clostridioides difficile infection: A systematic review and meta-analysis of randomized controlled trials;Journal of Infection and Chemotherapy;2022-11
2. Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection — An observational cohort study;International Journal of Infectious Diseases;2021-02
3. Efficacy and mechanism of actions of natural antimicrobial drugs;Pharmacology & Therapeutics;2020-12
4. Fecal microbiota transplantation (FMT) for C. difficile infection, just say ‘No’;Anaerobe;2019-12
5. Effectiveness of early use of fidaxomicin in preventing recurrence of Clostridium difficile infection;Journal of Hospital Infection;2019-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3